Hancock Whitney’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,936
Closed -$332K 836
2018
Q3
$332K Buy
+1,936
New +$332K 0.01% 734